The mechanisms underlying the formation of the glial scar after injury are poorly understood. In this report, we demonstrate that after cortical injury Olig2 is upregulated in reactive astrocytes coincident with proliferation of these cells. Short-term lineage tracing studies with glial subtype-restricted transgenic reporter lines indicate that Olig2-expressing cells in the astroglial but not the oligodendroglial lineage are the essential source of reactive astrocytes. In addition, cortical Olig2 ablation results in a decrease in proliferation of reactive astrocytes in response to injury. Cell-type-specific mutagenesis indicates that Olig2 ablation in GFAPϩ astrocytes and their precursors rather than in neuronal or oligodendroglial cells is responsible for the reduction of reactive astrocyte proliferation. Thus, our studies suggest that Olig2 is critical for postinjury gliosis.
Introduction
Reactive astrocytes, the main cellular component of the glial scar, play a crucial role in wound healing and remodeling in response to injury and disease in the CNS (Ridet et al., 1997; Bush et al., 1999) . Although regulation of astrocyte differentiation in the developing CNS is relatively well defined (Mehler, 2002; Sauvageot and Stiles, 2002; Sun et al., 2003) , the molecular mechanisms that control gliosis, the proliferation of reactive astrocytes after pathological insults, are not fully understood. The basic helix-loophelix (bHLH) transcription factor Olig2 plays a critical role in neural cell fate specification and is regulated by Sonic hedgehog signaling in the developing CNS (Rowitch, 2004) . Recent studies indicate that Olig2 is expressed in immature developing astrocytes and plays an important role in astrocyte development in the brain (Marshall et al., 2005; Cai et al., 2007) . In addition, Olig2 can be detected in reactive astrocytes in various injury models, suggesting a possible role in the formation of reactive glia (Buffo et al., 2005; Cassiani-Ingoni et al., 2006; Magnus et al., 2007) . However, at least two important questions regarding the role of Olig2 in reactive astrocyte formation remain unresolved. First, because Olig2 is expressed in progenitor cells of both oligodendrocyte and astrocyte lineages, it remains unclear whether Olig2-expressing reactive astrocytes are derived from either oligodendrocyte precursors (OPCs) or astrocyte lineage cells, or both. Second, although nucleo-cytoplasmic translocation of Olig2 from progenitor cells has been suggested to mediate brain injuryinduced astrocyte differentiation (Magnus et al., 2007) , it is not known whether Olig2 is genetically required for reactive astrocyte formation after brain injury. In this study, we attempt to determine the source of reactive astrocytes after brain injury by using lineage-specific transgenic reporter lines and dissect the role of Olig2 in reactive astrocyte formation using a cell-type-specific conditional mutagenesis approach.
Materials and Methods
Immunohistochemistry. Immunostaining methods with tissue sections from mouse brains were as described previously (Lu et al., 2002) . Double immunostaining was performed by simultaneous incubation with the antibodies of interest. The following antibodies were used: polyclonals, Olig2 (1:1000; a gift from Chuck Stiles, Harvard Medical School, Boston, MA), glial fibrillary acidic protein (GFAP; 1:500; Advanced Immunochemical), and NG2 (1:500; Millipore Bioscience Research Reagents). The following monoclonals were used: bromodeoxyuridine (BrdU; 1:100; BD Biosciences), GFAP (1:800; Sigma), rat PDGFR␣ (1:500; BD Biosciences), Ki67 (1:500; Neomarkers), vimentin (1:200; Sigma), and nestin (1:50; BD Biosciences). Microscopy was performed on a Zeiss confocal microscope LSM510. Goat anti-mouse, rat and goat anti-rabbit secondary antibodies conjugated to Cy2, Cy3, and Cy5 (Jackson ImmunoResearch) were used for double or triple labeling experiments.
Cortical injuries. For cortical contusion injury, a controlled cortical impact device was used to cause brain injury as described previously (Kernie et al., 2001) . A group of wild-type and Olig2 conditional mutants at 6 -8 weeks were used for the injury experiment. Cortical cryoinjury was performed according to the procedure described by Tatsumi et al. (2005) . Briefly, a lead probe (3 mm in diameter), prechilled with liquid nitrogen was placed on the cranium (1 mm caudal to the bregma and 2 mm lateral to the sagittal suture) for 30 s twice. The treatment reproducibly yielded a lesion that was ϳ3 mm in diameter and depth. BrdU (100 mg/kg) was administrated intraperitoneally at desired time points after injury to label dividing cells. Brains were harvested at desired postinjury days after 4 h BrdU pulse labeling and subjected to immunohistochemistry. All surgical procedures were performed under deep anesthesia induced by isoflurane.
Statistic analysis. Quantifications were performed from at least three animals of control and Olig2 mutant littermates. At least five lesionbearing cortical sections from each animal were analyzed for cell counting. Data are presented as mean Ϯ SD in the graphs. p values are from Student's two-tailed t test between control and experimental groups. For multiple comparisons, which were done using one-way ANOVA with post-test: Newman-Keuls multiple-comparison test. All protocols involving the use of animals were approved by the Institutional Animal Care and Use Committee at the University of Texas Southwestern Medical Center at Dallas.
Results
Olig2 expression in proliferative reactive astrocytes after brain injury A characteristic feature of gliosis, the upregulation of the expression of GFAP, is seen in many forms of brain injury including traumatic brain injury and stroke (Anderson et al., 2003; Pekny and Nilsson, 2005) . To examine the activity of Olig2-expressing cells in response to injury, we used a cortical contusion injury model that results in an expansion of nascent GFAP-expressing reactive astrocytes in the adult cortex (Kernie et al., 2001) . After acute cortical injury in wild-type mice, we observed a large population of Olig2ϩ cells within the lesion penumbra that express GFAP at day 2 postinjury (dpi 2) ( Fig. 1 A, B) , whereas those in a region more distal to the lesion lacked GFAP (Fig. 1C) . The fact that these GFAPϩ cells are reactive astrocytes is corroborated by coexpression of other markers for reactive astrocytes such as vimentin and nestin ( Fig. 1 D, E) . Similar results were also observed with cortical cryoinjury (Fig. 1 F-I ) (data not shown), in keeping with other injury models (Buffo et al., 2005; Tatsumi et al., 2005; Cassiani-Ingoni et al., 2006; Magnus et al., 2007) .
To determine the dynamics of Olig2 expression in GFAPϩ reactive astrocytes in response to injury, we measured the percentage GFAP-expressing cells that coexpress Olig2 at days 0, 1, 2, 3 and 7 d after cortical cryoinjury. We focus on the cortical cryoinjury because this injury model keeps the injury localized primarily to the ipsilateral cortex where its cellular effects are more easily tractable. Although essentially no GFAPϩ/Olig2ϩ cells are detected in the uninjured adult cortex (dpi 0), there is a significant increase in Olig2ϩ/GFAPϩ cells after injury. We observed the peak percentage of Olig2 expression among GFAPϩ reactive astrocytes (83 Ϯ 6%) at dpi 2 in the penumbra region adjacent to the lesion (Fig. 1 F) , indicating that the majority of, if not all, reactive astrocytes express Olig2 after acute injury. The increase of the percentage of Olig2 expression in reactive astrocytes is correlated to that of proliferation of reactive astrocytes (Fig. 1G) , and the highest percentage of proliferative reactive astrocytes (Ki67ϩ/GFAPϩ) was observed at dpi 2 (Fig. 1G) . Olig2 expression in GFAPϩ astrocytes decreases significantly beginning at dpi 7 to ϳ16%, as does the proliferation of GFAPϩ reactive astrocytes (Fig. 1 F, G) , suggesting that Olig2 is transiently expressed in nascent proliferative astrocytes after injury and its expression may correlate to reactive astrocyte proliferation.
To determine the proliferative state of these Olig2ϩ/GFAPϩ cells after acute cryoinjury, we performed BrdU pulse labeling 4 h before harvest to label rapidly proliferating cells. Approximately 53% of BrdUϩ cells detected were GFAPϩ cells, whereas a majority of these BrdUϩ/GFAPϩ cells (72 Ϯ 5%) expressed Olig2 in the lesion penumbra at dpi 2 ( Fig. 1 H) . To ensure that BrdUϩ/ GFAPϩ cells are proliferative rather than incorporating BrdU because of DNA repair, we coimmunostained with another proliferative marker, Ki67, which labels all phases of cycling cells except for G0. Essentially all of these GFAP-expressing BrdUϩ cells coexpress Ki67 (Fig. 1 I) without expressing active form of caspase-3 (data not shown), suggesting that these BrdUϩ/ Olig2ϩ/GFAPϩ cells formed in response to injury are proliferative reactive astrocytes rather than dying cells.
Olig2؉ cell populations in the astroglial but not oligodendroglial lineage respond to acute cortical injury by expression of GFAP Because Olig2 is expressed in both oligodendrocyte and astrocyte lineage cells in the developing brain (Marshall et al., 2005; Cai et al., 2007) , we further determined the cell types from which Olig2ϩ populations that respond to injury and form reactive astrocytes are derived. OPCs proliferate after CNS injury (Fancy et al., 2004; Tatsumi et al., 2005) , and have been suggested as a potential source for reactive astrocytes (Tatsumi et al., 2005) . To determine whether OPCs express the reactive astrocyte marker GFAP, we performed immunostaining for GFAP and an OPC marker, PDGFR␣, at different time points after cryoinjury. Even at dpi 2, when the rate of reactive astrocyte generation peaks, the population of GFAP-expressing reactive astrocytes in the lesion penumbra was distinct from that of PDGFR␣-expressing OPCs (Fig. 2 A, arrows) , although Olig2 expression is detected in both reactive GFAPϩ astrocytes and OPCs (Fig. 2 A) . Similarly, expression of NG2, another OPC marker, is hardly detectable among GFAPϩ cells (Fig. 2 B, J ). This is consistent with studies using other brain injury models, where NG2/GFAP-coexpressing cells were undetectable in the lesion area of the adult brain (Magnus et al., 2007) . Our observations suggest that either OPCs do not acquire GFAP after injury, or alternatively, they lose their classic OPC markers during the transition to reactive astrocytes. To address the latter possibility, we used a Pdgfr␣-hGFP knock-in line (Soriano, 1997 ) for short-term lineage tracing to track the fate of PDGFR␣ϩ cells after injury, given that expression of a stable form of histone H2B-fused-GFP (hGFP) knocked into the Pdgfr␣ locus can persist in daughter cells (Soriano, 1997; Kanda et al., 1998) . The injured cortices of Pdgfr␣-hGFP mice were examined for GFAP expression. Strikingly, we could not detect GFAP expression in Pdgfr␣-hGFPϩ cells at any time points such as dpi 1, 2, 3 and 7 (Fig. 2C ) (data not shown), whereas Olig2 was expressed in these Pdgfr␣-GFPϩ cells and GFAPϩ cells, two distinct cell populations (Fig. 2 D) . In addition, differentiated oligodendrocytes such as CC1ϩ cells do not acquire GFAP expression after injury (data not shown). These observations suggest that committed OPCs such as PDGFR␣ϩ cells and oligodendrocytes are not converted into GFAP-expressing reactive astrocytes after cortical injury.
To determine whether astrocyte-lineage cells, which express Olig2 at their immature stages (Cai et al., 2007) , respond to the injury by upregulation of GFAP, we performed brain injury on a gfa2-GFP transgenic line, wherein GFP expression directed by the gfa2 promoter was detected specifically in cells of the astrocyte lineage in the CNS using both innate GFP fluorescence and TSA amplified immunochemistry methods (Zhuo et al., 1997; Su et al., 2004) . In the cortex of gfa2-GFP mice after cryoinjury, the majority of GFP-expressing astrocytes (95 Ϯ 3%) were found to express GFAP in the penumbra region ipsilateral to the injury, whereas a minority, if any, of Pdgfr␣-hGFPϩ cells (Ͻ1%) express GFAP ( Fig. 2C, E, J ). This population of gfa2-GFP/GFAPϩ cells coexpresses Olig2, however, they are distinct from Olig2ϩ/ GFAP-cell populations (Fig. 2 E-I ) . Collectively, short-term lineage tracing studies with Pdgfr␣-hGFP and gfa2-GFP transgenic reporter lines suggest that Olig2ϩ cells in the astroglial but not oligodendroglial lineage are the major source of reactive astrocytes in response to cortical injury.
Olig2 is required for reactive astrocyte proliferation after cortical injury
To determine whether Olig2 is required for reactive astrocyte proliferation, we then examined the formation of reactive astrocytes in control and Olig2-mutant cortices. Because the assessment of Olig2 function in the adult brain has been hampered by the embryonic lethality of Olig2 null mice (Lu et al., 2002; Zhou and Anderson, 2002) , we used the Cre/lox system to ablate the floxed Olig2 allele in the cortex directed by human GFAP (hGFAP)-Cre activity (Zhuo et al., 2001; Cai et al., 2007) . The hGFAP promoter drives Cre recombinase expression in the majority of multipotent cortical progenitors and astrocyte lineage cells, as well as oligodendrocyte progenitors in the developing CNS (Zhuo et al., 2001; Malatesta et al., 2003; Yue et al., 2006; Cai et al., 2007) . The hGFAP-Cre activity ablates essentially all Olig2 expression in the cortex of Olig2Cko;hGFAPCre mice (Cko G ) (Cai et al., 2007) (Fig. 3 A, B) . In Cko G mice, although there is a reduction of astrocyte subpopulations in the white matter region, the number of astrocytes indicated by glutamine synthetase expression in the cortical gray matter is comparable with that in control mice despite GFAP upregulation in these astrocytes (Cai et al., 2007) . Thus, our assessment on reactive astrocyte formation is focused on the cortical gray matter of control and Cko G mice after cortical injury. Compared with the control (Fig. 3 A, C,E) , Olig2 expression in the Cko G mice is essentially absent in most cortical regions (Fig. 3 B, D,F ) . Only a small number of Olig2ϩ cells remain in the Cko G cortex, which are presumably the oligodendrocytes escaping hGFAP-Cre-mediated recombination (Fig. 3 D, G , arrowheads) because they do not express GFAP.
At dpi 2, the average percentage of proliferative reactive astrocytes (GFAPϩ/BrdUϩ) is significantly reduced from 13.2% in the control to 2.6% in the Cko G cortex (Fig. 3 , compare C, D, J ), as is the average number of GFAPϩ cells in lesion penumbra, which decreases from 137 Ϯ 23 in the control to 84 Ϯ 19 per unit area (0.1 mm 2 ) in the Cko G cortex ( p Ͻ 0.01). Consistently, the percentage of Ki67ϩ proliferative reactive astrocytes in lesion penumbra also decreases significantly in the absence of Olig2 from 55 Ϯ 9% in the control to 12 Ϯ 5% in the Cko G cortex ( p Ͻ 0.01) (Fig. 3, compare H, I ). The decrease of proliferating reactive astrocytes in the Olig2 mutant was also observed at other time points after cortical injury (data not shown). In addition, in contrast to intense GFAP expression and hypertrophic stellate morphology in reactive astrocytes within the lesion penumbra of control mice, astrocytes in the lesion of the Olig2 mutant Cko G cortex exhibit relatively weak GFAP expression and a thin, elongated morphology (Fig. 3, compare C,E and D, F ) .
Olig2 ablation specifically in neuronal and oligodendroglial cells does not affect reactive astrocyte formation in the injured cortex
Potential perturbation of neuronal development and function attributable to Olig2 ablation may influence reactive astrocyte formation. To determine whether Olig2 deletion from cortical neurons during early brain development will affect reactive astrocyte formation, we performed the cortical cryoinjury on the mice with Olig2 ablation in neuronal cells directed by synapsin1-Cre. Synapsin1-Cre activity commences in neuronal precursor cells from an early embryonic stage (embryonic day 12.5) (Zhu et al., 2001 ). We have not observed any detectable deficits in terms of the formation of neurons, oligodendrocytes and astrocytes in the developing and adult brain of Olig2Cko;Syn1-Cre (Cko S ) mice (Cai et al., 2007) . Similarly, we did not detect significant alteration in the formation and proliferation of reactive astrocytes after cortical cryoinjury in Cko S mice compared with wild-type mice (Fig. 3J ), in keeping with normal Olig2 expression in Cko S mice (Cai et al., 2007) . These observations suggest that ablation of the Olig2 allele in cortical neuronal precursor cells does not contribute significantly, if at all, to the reduced formation of reactive astrocytes.
In the cortex of Cko G mice, the majority of PDGFR␣ϩ OPCs are formed independent of Olig2 expression (Yue et al., 2006) . Given the essential role of Olig2 for OPC formation, the Olig2-negative OPCs are likely attributable to Olig2 ablation after the OPC fate has been specified from neural stem/progenitors. To determine the effects of cortical Olig2 ablation directed by hGFAP-Cre on OPC proliferation after cortical injury, we examined the expression of the proliferative marker Ki67 in OPCs. We observed a moderate reduction of the number of PDGFR␣ϩ OPCs two days after cryoinjury (Fig. 4 A, C) ; however, the average percentage of Ki67ϩ/PDGFR␣ϩ OPCs is significantly reduced from ϳ49% in the control to 28% in the Cko G cortex ( p Ͻ 0.01) (Fig. 4, compare B, D) . Thus, hGFAP-Cre-mediated ablation of Olig2 expression in a majority of oligodendrocyte progenitors inhibits their proliferation after injury.
To determine whether oligodendrocyte deficits and dysmyelination caused by Olig2 ablation may affect reactive astrocyte proliferation in the injured cortex, we then examined a myelindeficient mutant mice with Olig2 ablation specifically in oligodendrocytes and their precursors directed by Cnp1-Cre activity (Lappe-Siefke et al., 2003) . Compared with the control (Fig.  4 E) , Olig2Cko;cnp-Cre (Cko C ) mice exhibit severe myelinationdeficits in the cortex (Fig. 4 F) despite the presence of a small number of myelinating oligodendrocytes in the subcortical white matter. In contrast, these mice do not display abnormal astrocyte formation and GFAP alteration (Fig. 4 H) . Two days after cortical cryoinjury in Cko C mice, hypertrophic reactive astrocytes are formed in the absence of MBP expression and cortical myelination (Fig. 4 J compared with I) , as are proliferative (BrdUpositive) astrocytes (Fig. 4 L) . The percentage of BrdUϩ cells among GFAPϩ cells in the injured cortex is comparable between the control and Cko C mice (Fig. 3J ) . Thus, dysmyelination caused by oligodendrocyte-specific Olig2 ablation in Cko C mice does not result in a significant alteration of reactive astrocyte proliferation after cortical injury.
Discussion
In addition to being found in oligodendrocyte-lineage cells, Olig2 expression can be detected in reactive astrocytes in various injury models including stab wound injury, ischemia and experimental allergic encephalomyelitis (Buffo et A, B) and Cko G (Olig2c/-;hGFAP-Cre)(C, D) mice were immunostained with antibodies against PDGFR␣ and Ki67 as indicated. Arrows indicate PDGFR␣ϩ/Ki67ϩ cells. E-H, Cryoinjured cortices from control Ctrl C (Olig2c/ϩ;CNPCre) and Cko C (Olig2c/-;CNPCre) mice were immunostained with MBP (E, F ) and GFAP (G, H ). Arrowheads indicate the cortical gray matter. MBP expression is undetectable in the cortex of Cko C mice (F ) in contrast to strong MBP expression in control cortex (E). Arrows indicate the corpus callosum (cc). I-J, Penumbra regions from cortices of Ctrl C and Cko C mice after cryocortical injury at dpi 2 were immunostained with antibodies against GFAP (green) and MBP (red). Arrows indicate the GFAPϩ cells. Asterisks indicate the injury sites. K, L, Penumbra regions from cortices of Ctrl C (K ) and Cko C mice (L) after 4 h BrdU pulse at dpi 2 were immunostained with antibodies against GFAP and BrdU. Arrows indicate the GFAPϩ/BrdU double labeling cells. M, A schematic diagram shows a critical role of Olig2 for reactive astrocyte proliferation. In the wild-type cortex, Olig2 is upregulated in the preexisting astrocytes after cortical injury and promotes or permits proliferation of immature nascent reactive astrocytes. In the absence of Olig2, despite GFAP upregulation in cortical astrocytes (Cai et al., 2007) , reactive astrocytes fail to undergo proliferation after injury. Scale bars: A-D, 50 m; E-H, 50 m; I-L, 50 m.
from oligodendrocyte precursors after acute injury in the adult brain. Our data are consistent with expression of a DsRed reporter for NG2ϩ OPCs in NG2-DsRedBAC transgenic mice (Zhu et al., 2008) . DsRed was only detected in cells of the oligodendrocyte lineage but not in astrocytes, microglia or neurons in the developing brain (Zhu et al., 2008) . Fate mapping of NG2 cells with NG2creBAC transgenic mice indicates that the Cre reporter EGFP can be detected in a subpopulation of protoplasmic astrocytes in the gray matter of the ventrolateral forebrain; however, very few NG2 precursor-derived protoplasmic astrocytes were found in the dorsal cortex (Zhu et al., 2008) . This observation is in keeping with our present study in the dorsal cortex that the majority, if not all, of the OPCs (NG2ϩ or PDGFR␣ϩ cells) are not converted into astrocytes even after cortical injury.
Although downregulation of Olig2 in a stab wound injury model was found to induce neuronal production from progenitor cells in the lesion (Buffo et al., 2005) , we did not observe any significant alteration in neurogenesis by examining new neuronal markers such as doublecortin and Tuj1 under our injury conditions (data not shown). The discrepancy may potentially be attributable to the use of a dominant-negative form of Olig2 (Olig2VP16) in the study by Buffo et al. (2005) . In addition to inhibiting endogenous Olig2 function, Olig2VP16 could potentially interact with other transcriptional regulators to induce neurogenesis.
In the developing brain, Olig2 is expressed in immature astrocytes during early postnatal stages but downregulated in mature astrocytes in adulthood (Cai et al., 2007) . Re-expression of Olig2, together with nestin and/or vimentin, in astrocytes after cortical injury suggests that the preexisting mature astrocytes can regress into a more immature precursor form. Olig2 expression in proliferative reactive astrocytes suggests that Olig2 upregulation may promote or permit GFAPϩ astrocytes to enter a cycling state and become proliferative precursors (Fig. 4 M) . Indeed, reduction of reactive astrocyte proliferation in the cortex with Olig2 ablation directed by hGFAP-Cre indicates that Olig2 plays a critical role in the proliferation of nascent reactive astrocytes after cortical injury. Given that Olig2 is upregulated in reactive astrocytes and that Olig2 ablation in neuronal or oligodendroglial lineage cells does not significantly affect reactive astrocyte formation, reduction of reactive astrocyte proliferation in the absence of Olig2 is, at least in part, caused by a cell autonomous effect of Olig2 loss in reactive astrocytes after injury. The requirement of Olig2 for the proliferation of reactive astrocytes after injury is consistent with a role for Olig2 in directing glial subtype formation including astrocytes from subventricular zone progenitor cells in the developing brain (Marshall et al., 2005) . Thus, the crucial role of Olig2 in reactive astrocyte proliferation suggests that Olig2 could be a key determinant of glial scar formation after injury.
